|
🐜
|
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study
31 auth.
S. Mariotto,
S. Ferrari,
S. Monaco,
M. Benedetti,
Kathrin Schanda,
D. Alberti,
A. Farinazzo,
R. Capra,
C. Mancinelli,
N. de Rossi,
R. Bombardi,
L. Zuliani,
M. Zoccarato,
R. Tanel,
A. Bonora,
...
M. Turatti,
M. Calabrese,
A. Polo,
A. Pavone,
L. Grazian,
G. Sechi,
E. Sechi,
D. Urso,
R. Delogu,
Francesco Janes,
L. Deotto,
M. Cadaldini,
M. Bianchi,
G. Cantalupo,
M. Reindl,
A. Gajofatto
|
7 |
2017 |
7
🐜
|
|
🐬
|
Are Natalizumab and Fingolimod Analogous Second-Line Options for the Treatment of Relapsing-Remitting Multiple Sclerosis? A Clinical Practice Observational Study
A. Gajofatto,
M. Bianchi,
L. Deotto,
M. Benedetti
|
5 |
2014 |
5
🐬
|
|
🐜
|
Pain Modulation after Oromucosal Cannabinoid Spray (SATIVEX®) in Patients with Multiple Sclerosis: A Study with Quantitative Sensory Testing and Laser-Evoked Potentials
8 auth.
M. Turri,
F. Teatini,
F. Donato,
G. Zanette,
V. Tugnoli,
L. Deotto,
...
B. Bonetti,
G. Squintani
|
5 |
2018 |
5
🐜
|
|
🐜
|
Off-label thrombolysis versus full adherence to the current European Alteplase license: impact on early clinical outcomes after acute ischemic stroke
17 auth.
M. Cappellari,
G. Moretto,
N. Micheletti,
F. Donato,
G. Tomelleri,
G. Gulli,
M. Carletti,
G. Squintani,
T. Zanoni,
S. Ottaviani,
...
S. Romito,
Giorgio Tommasi,
A. Musso,
L. Deotto,
G. Gambina,
D. S. Zimatore,
P. Bovi
|
4 |
2014 |
4
🐜
|
|
🐜
|
Cortical and spinal excitability in patients with multiple sclerosis and spasticity after oromucosal cannabinoid spray
7 auth.
G. Squintani,
F. Donato,
M. Turri,
L. Deotto,
F. Teatini,
G. Moretto,
...
R. Erro
|
4 |
2016 |
4
🐜
|
|
🐜
|
Reversible cerebral ischemias: A comparative analysis of risk factors in TIAs and in RINDs
10 auth.
G. Gambina,
L. Corso,
L. Deotto,
G. Tarondi,
M. Brighenti,
C. Ciccarelli,
...
G. Preite,
G. Zardini,
M. Montanari,
V. Sbarbaro
|
0 |
1984 |
0
🐜
|
|
🐜
|
17. Pain modulation in patients with Multiple Sclerosis, pain and spasticity after oromucosal cannabinoid spray (THC/CBD): A study with quantitative sensory testing and laser evoked potentials
8 auth.
M. Turri,
F. Donato,
F. Teatini,
G. Zanette,
V. Tugnoli,
L. Deotto,
...
G. Moretto,
G. Squintani
|
0 |
2016 |
0
🐜
|
|
🐜
|
Familial cavernous hemangioma with atypical neuroimaging
14 auth.
M. G. Passarin,
A. Salviati,
G. Gambina,
F. Tezzon,
G. Tomelleri,
L. Deotto,
T. Zanoni,
P. Bovi,
M. Gerosa,
A. Nicolato,
...
C. Mazza,
P. Iuzzolino,
C. Ghimenton,
G. Ferrari
|
0 |
1996 |
0
🐜
|
